Osaic Holdings’s Benitec Biopharma BNTC Stock Holding History

Osaic Holdings’s Portfolio BNTC Stock Details BNTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13	Hold	1	–	–	﹤0.01%	7937
2026 Q1	$10	Hold	1	–	–	﹤0.01%	7740
2025 Q4	$13	Buy	+1	New	+$14	﹤0.01%	7752

Other funds holding BNTC

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Osaic Holdings's BNTC Position: Q2 2026 in Review

Osaic Holdings held its Benitec Biopharma (BNTC) position steady in Q2 2026 at 1 share worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #7937.

Osaic Holdings first reported a position in BNTC in Q4 2025 and has held it in 3 quarters since. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

Osaic Holdings held 1 share of Benitec Biopharma worth $13 as of Q2 2026.
Osaic Holdings left its Benitec Biopharma share count unchanged in Q2 2026.
Benitec Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7937 holding.
Osaic Holdings first reported a position in Benitec Biopharma in Q4 2025 and has held it in 3 quarters since.
87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.